| Literature DB >> 22833544 |
Cleia T Amaral1, Núbia N Pontes, Bruna L L Maciel, Hugo S M Bezerra, Ana Nataly A B Triesta, Selma M B Jeronimo, Stephen E McGowan, Vera M Dantas.
Abstract
OBJECTIVE: To assess whether vitamin A deficiency alters the recovery of total respiratory resistance (TRR) following acute upper respiratory tract infection (URI).Entities:
Mesh:
Substances:
Year: 2012 PMID: 22833544 PMCID: PMC7167945 DOI: 10.1002/ppul.22621
Source DB: PubMed Journal: Pediatr Pulmonol ISSN: 1099-0496
Demographic Composition of the Study Groups
| Total (n = 177) | URI (n = 74) | URI‐wheezing (n = 52) | Control (n = 51) |
| |
|---|---|---|---|---|---|
| Age (months; mean ± SD) | 59.0 ± 1.58 | 57.4 ± 6.95 | 59.0 ± 6.80 | 60.6 ± 6.41 | 0.037 |
| Gender n (%) | |||||
| Male | 89 (50.3) | 38 (51.4) | 30 (57.7) | 21 (41.2) | 0.238 |
| Female | 88 (49.7) | 36 (48.6) | 22 (42.3) | 30 (58.8) | |
One‐way ANOVA.
χ2.
Anthropometric Characteristics of the Groups
|
| Control (n = 51) | URI (n = 74) | URI‐wheezing (n = 52) | Total (n = 177) |
|
|---|---|---|---|---|---|
| Height/Age | −0.21 ± 0.88 | −0.43 ± 1.02 | −0.15 ± 0.89 | −0.29 ± 0.95 | 0.216 |
| Weight/Age | 0.34 ± 1.09 | 0.09 ± 1.14 | 0.29 ± 1.18 | 0.22 ± 1.14 | 0.474 |
| Weight/Height | 0.67 ± 1.87 | 0.54 ± 1.32 | 0.50 ± 1.18 | 0.56 ± 1.42 | 0.899 |
Mean ± SD.
Of the 177 children, a total of 101 (24 controls, 47 URI and 30 URI‐wheezing) were used to calculate the ratio of weight (kg) per height (cm), according to the World Health Organization tables for calculating Z‐scores (WHO 2006) only children with height up to 121 cm should be used.
Vitamin A and MRDR Status
| Levels of vitamin A | Total (n = 153), n (%) | Control (n = 38), n (%) | URI (n = 69), n (%) | URI‐wheezing (n = 46), n (%) |
|
|---|---|---|---|---|---|
| Group mean retinol (µg/dl) | 35.81 ± 19.47 | 56.78 ± 29.82 | 32.37 ± 13.12 | 18.29 ± 6.83 | 0.000 |
| Retinol > 30 µg/dl | 69 (45.1) | 30 (78.9) | 36 (52.2) | 3 (6.5) | |
| Retinol 20–30 µg/dl | 41 (26.8) | 7 (18.4) | 20 (29.0) | 14 (30.4) | 0.001 |
| Retinol 10–20 µg/dl | 37 (24.2) | 1 (2.6) | 12 (17.4) | 24 (52.2) | |
| Retinol < 10 µg/dl | 6 (3.9) | 0 (0.0) | 1 (1.4) | 5 (10.9) | |
| Group mean MRDR | 0.031 ± 0.030 | 0.007 ± 0.006 | 0.066 ± 0.045 | 0.021 ± 0.021 | 0.000 |
| MRDR <0.030 | 90 (59.0) | 38 (100.0) | 20 (29.0) | 32 (69.6) | |
| MRDR 0.030–0.060 | 22 (14.2) | 0 (0.0) | 9 (13.0) | 13 (28.3) | 0.001 |
| MRDR >0.060 | 41 (26.8) | 0 (0.0) | 40 (58.0) | 1 (2.2) |
Mean ± SD.
1‐way ANOVA for differences across all subject and retinol groups.
P < 0001 compared to control and URI without wheezing using 1‐way ANOVA.
P < 0.001 compared to control and URI with wheezing using 1‐way ANOVA.
χ2 test for differences across all subject and retinol groups.
Serum Constituents That Can Be Altered by Inflammatiion or Infection
| Parameters | Total | Control (n = 38), mean ± SD | URI (n = 69), mean ± SD | URI‐wheezing sibilância (n = 46), mean ± SD |
|
|---|---|---|---|---|---|
| C Reactive protein (mg/L) | 2.7 ± 0.5 | 2.1 ± 0.7 | 3.0 ± 3.1 | 3.0 ± 3.0 | 0.172 |
| Albumin‡ (g/dl) | 3.7 ± 0.17 | 3.9 ± 0.4 | 3.8 ± 0.5 | 3.5 ± 0.7 | 0.020 |
| Transferrin (mg/dl) | 234.3 ± 41.7 | 237.0 ± 34.1 | 224.1 ± 39.2 | 241.9 ± 53.0 | 0.059 |
| Transferrin saturation (%) | 30.4 ± 17.2 | 31.5 ± 18.5 | 31.3 ± 18.5 | 25.9 ± 13.1 | 0.062 |
| Iron (µg/dl) | 55.9 ± 7.7 | 60.4 ± 37.8 | 51.4 ± 42.0 | 56.0 ± 52.9 | 0.571 |
| Retinol binding protein 4 (µg/ml) | 19.6 ± 9.8 | 21.3 ± 11.0 | 19.8 ± 10.4 | 17.7 ± 6,7 | 0.203 |
Mean ± SD.
Post‐hoc test showed a difference in the level of albumin between the control group and the group with URI‐wheezing.
Respiratory Resistance (R5Hz) of the Groups During Symptoms and 3 Weeks Post‐Respiratory Symptoms
| Groups | R5Hz |
| |||||
|---|---|---|---|---|---|---|---|
| Initial | Recovery (mean ± SD) | ||||||
| n | kPa/(L/s) | % | n | kPa/(L/s) | % | ||
| Control | 51 | 1.08 ± 0.21 | 93.6 ± 18.0 | — | — | — | |
| URI | 74 | 1.15 ± 0.20 | 97.2 ± 16.6 | 72 | 1.13 ± 0.19 | 93.6 ± 16.0 | 0.022 |
| URI‐wheezing | 52 | 1.47 ± 0.32 | 126.0 ± 26.9 | 51 | 1.14 ± 0.26 | 96.8 ± 21.5 | 0.000 |
Mean ± SD.
Two‐way repeated measure ANOVA on ranks comparing the initial and recovery TRR for individual subjects. %, percent predicted.
Significant difference in the initial R5Hz between URI and URI‐wheezing by the Post‐hoc test, (P = 0.0000); but no difference between URI and controls (P > 0.05).
Figure 1Decrease in TRR is inversely related to vitamin A stores during URI. The second measurement of TRR (3 weeks after initial) was subtracted from the initial measurement (during acute symptoms of URI) to calculate the change in R5Hz in kPa/(L/s) (Δ R5Hz) for each subject. Negative indicates increase in TRR. MRDR is ratio of serum 3,4 didehydroretinol to retinol. Line is linear regression fit. For URI‐group, (A) R = 0.301 general linear model P = 0.015. B: R = 0.29 general linear model P = 0.02 (C) and (D) URI‐wheezing, slopes of regression lines did not differ significantly from zero.
Smaller Decrement in TRR After Recovery of Symptoms Correlates With Lower Higher MRDR in Children With URI, but Without Wheezing
| MRDR | TRR (R5Hz | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| Symptomatic phase | Post‐recovery |
| |||||||
| n | % subjects | TRR (mean ± SD) | % predicted TRR | n | % subjects | TRR (mean ± SD) | % predicted TRR | ||
| >0.060 | 40 | 58.0 | 1.14 ± 0.22 | 96.0 ± 18.2 | 39 | 58.2 | 1.15 ± 0.21 | 96.3 ± 16.9 | 0.565 |
| 0.030–0.060 | 9 | 13.0 | 1.17 ± 0.16 | 98.8 ± 11.0 | 9 | 13.4 | 1.04 ± 0.09 | 86.5 ± 6.2 | 0.020 |
| <0.030 | 20 | 29.0 | 1.15 ± 0.17 | 99.1 ± 16.0 | 19 | 28.3 | 1.05 ± 0.16 | 88.2 ± 15.0 | 0.003 |
| Total | 69 | 100.0 | 67 | 100.0 | |||||
Mean ± SD.
Two‐way repeated measure ANOVA on ranks showed a significant difference between the symptomatic and post‐recovery measurements when the MRDR was between 0.030–0.060 and <0.03.
Mean ± SEM.